CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,679 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 8,504 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 1,478 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Customer Officer gave up 9,162 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 9,035 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 584 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 514 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Customer Officer gave up 1,685 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,370 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 1,704 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Customer Officer gave up 711 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 719 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 557 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 715 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 391 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 34 · 672 filings